Does METHANDROSTENOLONE Cause Hepatic neoplasm? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic neoplasm have been filed in association with METHANDROSTENOLONE. This represents 9.0% of all adverse event reports for METHANDROSTENOLONE.
7
Reports of Hepatic neoplasm with METHANDROSTENOLONE
9.0%
of all METHANDROSTENOLONE reports
7
Deaths
7
Hospitalizations
How Dangerous Is Hepatic neoplasm From METHANDROSTENOLONE?
Of the 7 reports, 7 (100.0%) resulted in death, 7 (100.0%) required hospitalization, and 6 (85.7%) were considered life-threatening.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHANDROSTENOLONE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does METHANDROSTENOLONE Cause?
Drug abuse (48)
Intentional product misuse (14)
Multiple organ dysfunction syndrome (8)
Acute kidney injury (7)
Hypertension (7)
Intra-abdominal haemorrhage (7)
Poisoning (7)
Cardiac failure (6)
Left ventricular hypertrophy (5)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)